Pediatric Antibiotic Dosing in Extracorporal Membrane Oxygenation (PADECMO)

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeUp to 15
SponsorUniversity Hospital, Ghent

About this trial

Pharmacokinetics of antibiotics in critically ill neonates, infants and children on extracorporeal membrane oxygenation (ECMO).

Eligibility criteria

Qualifiers

patients admitted to the pediatric intensive care unit or cardiac intensive care unit

patient age : 1,8 kg-15 years

patient receiving antibiotic treatment (piperacillin-tazobactam, meropenem, amoxicillin-clavulanate, cephazolin, vancomycin, teicoplanin, ciprofloxacin, amikacin)

intra-arterial or intravenous access other than the drug infusion line available for blood sampling (arterial line is preferred)

Disqualifiers

no catheter in place for blood sampling

absence of parental/patient consent

known hypersensitivity to beta-lactam antibiotics and ciprofloxacin

Trial design

Treatments tested in this trial

  • Amoxicillin-clavulanate
  • Piperacillin-tazobactam
  • Meropenem
  • Cefazolin
  • Vancomycin
  • Teicoplanin
  • Ciprofloxacin
  • Amikacin

Treatment groups

300 Participants
are divided into 8 treatment groups

8

Treatment groups

See each treatment group below.

Sponsors and collaborators